Idebenone alleviates rotenone-induced mitochondrial dysfunction through mitophagy and mitochondrial biogenesis in muscle cells
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Chen Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mitochondrial Medicine Laboratory, Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong 266035, China; Department of Central Laboratory, Q…. Hauptthemen laut MEDLINE: Ubiquinone, Rotenone, Mitophagy, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, Taishan Scholar Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Idebenone, a synthetic quinone analog of coenzyme Q10, is a well-characterized antioxidant with clinical applications in treating diseases associated with mitochondrial dysfunction. However, it remains unclear whether idebenone can mitigate rotenone-induced oxidative stress and mitochondrial dysfunction in muscle cells. In this study, exposure of C2C12 myoblasts to rotenone resulted in a significant increase in cell death, intracellular and mitochondrial reactive oxygen species, and the activation of mitophagy and autophagy, as evidenced by altered expression levels of PINK1, PARKIN, and p62/SQSTM1. Additionally, elevated mitochondrial fission (measured by DRP1 and FIS1 expression) and a decrease in energy production (assessed via Seahorse analysis) were observed compared to untreated cells. The translocation of cytoplasmic DRP1 to the mitochondria was further demonstrated by its colocalization with TOM20. Remarkably, treatment with idebenone reversed these effects, and pharmacological inhibition of PGC1A abolished the protective effects of idebenone on mitochondrial biogenesis and function. Our findings suggest that idebenone ameliorates rotenone-induced apoptosis, oxidative stress, and mitochondrial damage in C2C12 cells, supporting its potential therapeutic role in the treatment of skeletal muscle atrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mitochondrial Medicine Laboratory, Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong 266035, China; Department of Central Laboratory, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong Universi…
- Mitochondrial Medicine Laboratory, Qilu Hospital (Qingdao), Shandong University, Qingdao, Shandong 266035, China; Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China.
- Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China. Electronic address: xiawei@qdu.edu.cn.
Förderung
- Shandong Province Natural Science Foundation
- Taishan Scholar Foundation of Shandong Province
- National Natural Science Foundation of China
- Shandong University
Zitieren
APA
Zhang, C., Li, M., Meng, L., Xia, W., & Wu, G. (2026). Idebenone alleviates rotenone-induced mitochondrial dysfunction through mitophagy and mitochondrial biogenesis in muscle cells. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112221
Vancouver
Zhang C, Li M, Meng L, Xia W, Wu G. Idebenone alleviates rotenone-induced mitochondrial dysfunction through mitophagy and mitochondrial biogenesis in muscle cells. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112221
BibTeX
@article{Zhang2026,
author = {Zhang, Chen and Li, Mei and Meng, Liying and Xia, Wei and Wu, Guanzhao},
title = {Idebenone alleviates rotenone-induced mitochondrial dysfunction through mitophagy and mitochondrial biogenesis in muscle cells},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112221}
}
EUVIMED